XML 26 R15.htm IDEA: XBRL DOCUMENT v3.23.3
Stockholders' Equity
9 Months Ended
Sep. 30, 2023
Stockholders' Equity  
Stockholders' Equity

Note 8. Stockholders’ Equity

Condensed Consolidated Statements of Stockholders’ Equity

(in thousands)

The changes in stockholders’ equity by component for the three and nine months ended September 30, 2023 are as follows:

 

 

 

 

 

 

 

 

 

Accumulated

Other

AXT, Inc.

 

 

 

Total

 

Preferred

 

Common

 

Additional

 

Accumulated

 

Comprehensive

Stockholders’

 

Noncontrolling

 

Stockholders’

  

Stock

  

Stock

  

Paid-In Capital

  

Deficit

  

Income (Loss)

  

Equity

  

Interests

  

Equity

 

Balance as of December 31, 2022

 

$

3,532

 

$

44

 

$

235,308

 

$

(14,159)

 

$

(3,118)

$

221,607

 

$

23,293

 

$

244,900

Common stock options exercised

8

8

8

Investment in subsidiary with noncontrolling interest

(36)

(36)

239

203

Investment in subsidiary with redeemable noncontrolling interest

(36)

(36)

(36)

Noncontrolling interest portion of Tongmei stock-based compensation

33

33

(16)

17

Stock-based compensation

717

717

717

Tongmei stock-based compensation

198

198

198

Net loss

(3,348)

(3,348)

(169)

(3,517)

Other comprehensive income

858

858

70

928

Balance as of March 31, 2023

$

3,532

$

44

$

236,192

$

(17,507)

$

(2,260)

$

220,001

$

23,417

$

243,418

Common stock options exercised

2

2

2

Investment in subsidiary with noncontrolling interest

(74)

(74)

380

306

Investment in subsidiary with redeemable noncontrolling interest

(75)

(75)

(75)

Noncontrolling interest portion of Tongmei stock-based compensation

31

31

(14)

17

Stock-based compensation

720

720

720

Tongmei stock-based compensation

192

192

192

Net loss

(5,089)

(5,089)

38

(5,051)

Other comprehensive income (loss)

(5,915)

(5,915)

(623)

(6,538)

Balance as of June 30, 2023

 

$

3,532

$

44

$

236,988

$

(22,596)

$

(8,175)

$

209,793

$

23,198

$

232,991

Common stock options exercised

Investment in subsidiary with noncontrolling interest

(43)

(43)

242

199

Investment in subsidiary with redeemable noncontrolling interest

(44)

(44)

(44)

Noncontrolling interest portion of Tongmei stock-based compensation

(139)

(139)

68

(71)

Stock-based compensation

703

703

703

Tongmei stock-based compensation

188

188

188

Net loss

(5,823)

(5,823)

(236)

(6,059)

Other comprehensive income (loss)

(406)

(406)

(54)

(460)

Balance as of September 30, 2023

 

$

3,532

$

44

$

237,653

$

(28,419)

$

(8,581)

$

204,229

$

23,218

$

227,447

Net loss and Other comprehensive loss attributable to redeemable noncontrolling interests were $356,000 and $55,000, respectively, for the three months ended September 30, 2023 and $807,000 and $615,000, respectively, for the nine months ended September 30, 2023 and are not shown in the table above.

The changes in stockholders’ equity by component for the three and nine months ended September 30, 2022 are as follows:

 

 

 

 

 

 

 

 

 

Accumulated

Other

AXT, Inc.

 

 

 

Total

 

Preferred

 

Common

 

Additional

 

Accumulated

 

Comprehensive

Stockholders’

 

Noncontrolling

 

Stockholders’

  

Stock

  

Stock

  

Paid-In Capital

  

Deficit

  

Income (Loss)

  

Equity

  

Interests

  

Equity

Balance as of December 31, 2021

 

$

3,532

 

$

43

 

$

231,622

 

$

(29,970)

 

$

6,302

$

211,529

 

$

18,317

 

$

229,846

Investment in subsidiary with noncontrolling interest

(410)

(410)

204

(206)

Noncontrolling interest portion of Tongmei stock-based compensation

17

17

(7)

10

Stock-based compensation

875

875

875

Tongmei stock-based compensation

213

213

213

Net income

3,165

3,165

389

3,554

Investment in subsidiary from noncontrolling interest

1,887

1,887

Other comprehensive income

327

327

45

372

Balance as of March 31, 2022

$

3,532

$

43

$

232,317

$

(26,805)

$

6,629

$

215,716

$

20,835

$

236,551

Common stock options exercised

146

146

146

Investment in subsidiary with noncontrolling interest

(268)

(268)

1,447

1,179

Noncontrolling interest portion of Tongmei stock-based compensation

32

32

(16)

16

Stock-based compensation

919

919

919

Tongmei stock-based compensation

218

218

218

Net income

5,546

5,546

450

5,996

Other comprehensive income (loss)

(5,992)

(5,992)

(569)

(6,561)

Balance as of June 30, 2022

 

$

3,532

$

43

$

233,364

$

(21,259)

$

637

$

216,317

$

22,147

$

238,464

Common stock options exercised

371

371

371

Investment in subsidiary with noncontrolling interest

(259)

(259)

1,048

789

Noncontrolling interest portion of Tongmei stock-based compensation

20

20

(4)

16

Stock-based compensation

921

921

921

Tongmei stock-based compensation

115

115

115

Net income

5,759

5,759

446

6,205

Other comprehensive income (loss)

(6,094)

(6,094)

(628)

(6,722)

Balance as of September 30, 2022

 

$

3,532

$

43

$

234,532

$

(15,500)

$

(5,457)

$

217,150

$

23,009

$

240,159

Net income and Other comprehensive loss attributable to redeemable noncontrolling interests were $525,000 and $635,000, respectively, for the three months ended September 30, 2022, and $1.5 million and $1.2 million, respectively, for the nine months ended September 30, 2022 not shown in the table above.

There were no reclassification adjustments from accumulated other comprehensive income (loss) for the three and nine months ended September 30, 2023 and 2022.

Stock Repurchase Program

On October 27, 2014, our Board of Directors approved a stock repurchase program pursuant to which we may repurchase up to $5.0 million of our outstanding common stock.  These repurchases can be made from time to time in the open market and are funded from our existing cash balances and cash generated from operations. During 2015, we repurchased approximately 908,000 shares at an average price of $2.52 per share for a total purchase price of approximately $2.3 million under the stock repurchase program.  No shares were repurchased from 2016 through 2022. During the three and nine months ended September 30, 2023, we did not repurchase any shares under the approved stock repurchase program. As of September 30, 2023, approximately $2.7 million remained available for future repurchases under this program. Currently, we do not plan to repurchase additional shares.